Euroapi Company Header Euroapi Company Header

X

Find the latest Drugs in Development and Pipeline Prospector News of MEDSIR.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
MEDSIR
Spain_new Flag
Country
Country
Spain
Address
Address
MEDSIR BCN Torre Glòries - Planta 27, Avinguda Diagonal, 211, 08018 Barcelona
Telephone
Telephone
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

The collaboration aims to evaluate the safety and efficacy of Debio 0123, Debiopharm's investigational, potential best-in-class WEE1 inhibitor, together with Trodelvy (sacituzumab govitecan).


Lead Product(s): Debio 0123,Sacituzumab Govitecan

Therapeutic Area: Oncology Product Name: Debio 0123

Highest Development Status: PreclinicalProduct Type: Small molecule

Partner/Sponsor/Collaborator: Debiopharm

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration May 28, 2024

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY